TRPV4 and malignant colon neoplasm: In this study, we showed that TRPV4 knockdown impaired the activation of AKT in colon cancer cells, consequently leading to inactivation of the mTOR and S6K pathway, and attenuated phosphorylation of 4E-BP1 and S6 ribosomal protein.